{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:07:47Z","timestamp":1791990467187,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T00:00:00Z","timestamp":1565827200000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Adolfo Lutz Institute"},{"name":"Secretary of Health of the State of S\u00e3o Paulo"},{"DOI":"10.13039\/100004319","name":"Pfizer, Inc., USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The National Council for Scientific and Technological Development\/CNPq","award":["302338\/2018-7"],"award-info":[{"award-number":["302338\/2018-7"]}]},{"name":"The National Council for Scientific and Technological Development\/CNPq","award":["306096\/2010-2"],"award-info":[{"award-number":["306096\/2010-2"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2019.07.043","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T17:21:29Z","timestamp":1563988889000},"page":"5357-5363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil"],"prefix":"10.1016","volume":"37","author":[{"given":"Maria-Cristina de C.","family":"Brandileone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemeire C.","family":"Zanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanta C.G.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Cassiolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula S. de","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maristela M.","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio T.","family":"Higa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Minamisava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Lucia","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.07.043_b0005","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.07.043_b0010","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S1473-3099(17)30396-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015","volume":"17","author":"Troeger","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.043_b0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.043_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/394368","article-title":"Nasopharyngeal bacterial carriage in the conjugate vaccine era with a focus on pneumococci","volume":"2015","author":"Devine","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2019.07.043_b0025","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2017.04.019","article-title":"Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: the emergence of multidrug resistant serotype 6C","volume":"35","author":"Neves","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.043_b0030","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.07.043_b0035","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/521833","article-title":"Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community randomized trial","volume":"196","author":"O\u2019Brien","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.043_b0040","doi-asserted-by":"crossref","first-page":"e1001517","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites","volume":"10","author":"Feikin","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2019.07.043_b0045","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1586\/14760584.5.5.651","article-title":"Nasopharyngeal colonization: a target for pneumococcal vaccination","volume":"5","author":"K\u00e4yhty","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.07.043_b0050","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/aje\/kwt156","article-title":"Using pneumococcal carriage data to monitor postvaccination changes in invasive disease","volume":"178","author":"Weinberger","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2019.07.043_b0055","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-2600(14)70060-8","article-title":"Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study","volume":"2","author":"Domingues","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2019.07.043_b0060","unstructured":"Brazil. Minist\u00e9rio da sa\u00fade. Novo calend\u00e1rio de vacina\u00e7\u00e3o 2017. https:\/\/pebmed.com.br\/novo-calendario-nacional-de-vacinacao-do-ministerio-da-saude-para-2017\/ (accessed February 17, 2017)."},{"key":"10.1016\/j.vaccine.2019.07.043_b0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/21645515.2015.1117713","article-title":"Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: a time-series analysis","volume":"12","author":"Andrade","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.07.043_b0070","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.vaccine.2018.04.010","article-title":"Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil","volume":"36","author":"Brandileone","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.043_b0075","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1016\/j.vaccine.2016.09.027","article-title":"Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in S\u00e3o Paulo, Brazil","volume":"34","author":"de C. Brandileone","year":"2016","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2019.07.043_b0080","doi-asserted-by":"crossref","first-page":"e0208211","DOI":"10.1371\/journal.pone.0208211","article-title":"Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil","volume":"2018","author":"Cassiolato","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.07.043_b0085","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/01.inf.0000049347.42983.77","article-title":"Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae","volume":"22","author":"O\u2019Brien","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.07.043_b0090","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1128\/JCM.39.3.1021-1024.2001","article-title":"Evaluation of a medium (stgg) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies","volume":"39","author":"O\u2019Brien","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.07.043_b0095","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1128\/JCM.02243-09","article-title":"Revisiting pneumococcal carriage by use of broth enrichment and pcr techniques for enhanced detection of carriage and serotypes","volume":"48","author":"Carvalho","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.07.043_b0100","unstructured":"World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC). Laboratory methods for diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. 2nd ed. WHO;2011."},{"key":"10.1016\/j.vaccine.2019.07.043_b0105","unstructured":"CDC (Centers for Disease Control and Prevention). Centers for Diseases Control and Prevention 2016. https:\/\/www.cdc.gov\/streplab\/pcr.html (accessed January 17, 2016)."},{"key":"10.1016\/j.vaccine.2019.07.043_b0110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/JCM.44.1.124-131.2006","article-title":"Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates","volume":"44","author":"Pai","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.07.043_b0115","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/JCM.02927-12","article-title":"Sequential triplex real-time pcr assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden","volume":"51","author":"Pimenta","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.07.043_b0120","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/JCM.02498-06","article-title":"Evaluation and improvement of real-time PCR assays targeting lyta, ply, and psaa genes for detection of pneumococcal DNA","volume":"45","author":"Carvalho","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.07.043_b0125","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3201\/eid1002.030759","article-title":"Real-time reverse transcription-polymerase chain reaction assay for sars-associated coronavirus","volume":"10","author":"Emery","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.043_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020675","article-title":"Incorporation of real-time PCR into routine public health surveillance of culture negative bacterial meningitis in S\u00e3o Paulo, Brazil","volume":"6","author":"Sacchi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.07.043_b0135","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1099\/00221287-144-11-3049","article-title":"A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease","volume":"144","author":"Enright","year":"1998","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2019.07.043_b0140","unstructured":"Multi Locus Sequence Type (MLST). Streptococcus pneumoniae MLST Databases 2017. http:\/\/pubmlst.org\/spneumoniae (accessed July 31, 2017)."},{"key":"10.1016\/j.vaccine.2019.07.043_b0145","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1128\/JB.186.5.1518-1530.2004","article-title":"eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data","volume":"186","author":"Feil","year":"2004","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.07.043_b0150","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. No Title. M100-19. 19th Infor, 2009."},{"issue":"7","key":"10.1016\/j.vaccine.2019.07.043_b0155","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/S2214-109X(14)70224-4","article-title":"Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies","volume":"2","author":"Hammitt","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2019.07.043_b0160","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.vaccine.2013.11.028","article-title":"Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada","volume":"32","author":"De Wals","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.043_b0165","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.vaccine.2018.03.001","article-title":"Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland","volume":"36","author":"Rinta-Kokko","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.043_b0170","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jac\/dkp210","article-title":"Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain","volume":"64","author":"Ardanuy","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2019.07.043_b0175","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/jir052","article-title":"Shifting genetic structure of invasive serotype 19a pneumococci in the United States","volume":"203","author":"Beall","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.043_b0180","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19a in the United States, 2005","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"issue":"1780\u20131790","key":"10.1016\/j.vaccine.2019.07.043_b0185","first-page":"e1","article-title":"Comparison of the impact of pneumococcal conjugate vaccine 10 or pneumococcal conjugate vaccine 13 on invasive pneumococcal disease in equivalent populations","volume":"65","author":"Naucler","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.043_b0190","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4067\/S0716-10182016000300009","article-title":"Opini\u00f3n del Comit\u00e9 Consultivo de Inmunizaciones Sociedad Chilena de Infectolog\u00eda: vacuna neumoc\u00f3ccica conjugada en ni\u00f1os y la emergencia de serotipo 19a","volume":"33","author":"Potin","year":"2016","journal-title":"Rev Chil Infectolog\u00eda"},{"key":"10.1016\/j.vaccine.2019.07.043_b0195","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.vaccine.2013.12.024","article-title":"Characterization of Streptococcus pneumoniae invasive serotype 19A isolates recovered in Colombia","volume":"32","author":"Ramos","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.043_b0200","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jinf.2018.06.004","article-title":"The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: a systematic review and meta-analysis","volume":"77","author":"Balsells","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2019.07.043_b0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1469-0691.2009.02726.x","article-title":"Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae","volume":"15","author":"Dagan","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2019.07.043_b0210","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1086\/593339","article-title":"Differential effects of pneumococcal vaccines against serotypes 6A and 6C","volume":"198","author":"Park","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.043_b0215","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1086\/657070","article-title":"Pre- and post-conjugate vaccine epidemiology of pneumococcal serotype 6c invasive disease and carriage within Navajo and white mountain Apache communities","volume":"51","author":"Millar","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.043_b0220","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1128\/JCM.02207-10","article-title":"Increase in prevalence of Streptococcus pneumoniae serotype 6c at eight children\u2019s hospitals in the United States from 1993 to 2009","volume":"49","author":"Green","year":"2011","journal-title":"J Clin Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1930934X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1930934X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:37:00Z","timestamp":1759401420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1930934X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":44,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X1930934X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}